Jose Munoz-Olaya

Jose Munoz-Olaya possesses extensive experience in the biotechnology and pharmaceutical sectors, holding key leadership roles in several prominent companies. As Chief Scientific Officer and Scientific Advisor at Valink Therapeutics from February 2022 to December 2023, Munoz-Olaya contributed to advancing scientific initiatives. Previously, at Takeda, Munoz-Olaya served as Director and Head of Preclinical for Adaptate Biotherapeutics, overseeing the transition of projects from candidate selection to clinical development. Additional roles included Co-leader of Immune Cell Engagers at AstraZeneca and Team Leader of Drug Discovery & Preclinical Translational Pharmacology at F-star Therapeutics, where Munoz-Olaya led significant projects from discovery through clinical trials. Munoz-Olaya's academic background includes a BSc in Molecular Genetics in Biotechnology from the University of Sussex and a PhD in Molecular Biology from Universitat de Barcelona.